Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Chemico-Biological Interactions

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-2797(85)80135-6PMID 4075437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

  1985cited by this paper
• The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.

  1985cited by this paper
• A simple method for the inactivation of monofunctionally DNA-bound cis-diamminedichloroplatinum (II).

  1984cited by this paper
• S1 nuclease sensitivity to cis- and trans-diamminedichloroplatinum(II) modified DNAS: influence of (G+C) content and nucleotide sequence.

  1984cited by this paper
• Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

  1983cited by this paper
• Physicochemical and Structural Studies of the In Vitro Interactions between Platinum(II) Compounds and DNA

  1983cited by this paper
• Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid

  1983cited by this paper
• Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation.

  1982cited by this paper
• Cis-diamminedichloroplatinum(II) modified DNA stimulates far greater levels of S1 nuclease sensitive regions than does the modification produced by the trans- isomer.

  1982cited by this paper
• Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.

  1982cited by this paper
• Development and possible use of immunological techniques to detect individual exposure to carcinogens: International Agency for Research on Cancer/International Programme on Chemical Safety Working Group Report.

  1982cited by this paper
• New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].

  1982cited by this paper
• Cis- and trans-diamminedichloroplatinum(II) binding products different tertiary structural changes on SV40 DNA.

  1982cited by this paper
• Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II).

  1981cited by this paper
• Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.

  1981cited by this paper
• The mechanism of action of antitumor platinum compounds.

  1979cited by this paper
• The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents.

  1966cited by this paper

• Development of Comprehensive Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA-DNA Cross-Links

  2022cites this paper
• DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine

  2016cites this paper
• Analytical approaches to investigating metal-containing drugs.

  2015cites this paper
• Measuring DNA damage and associated epigenetic changes genome-wide in cells following exposure to platinum analogue chemotherapeutic drugs

  2014cites this paper
• Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

  2013cites this paper
• Overexpression of Escherichia coli nucleotide excision repair genes after cisplatin-induced damage.

  2013cites this paper
• Mechanisms Of Genome Stability In The Hyperthermophilic Archaeon Sulfolobus acidocaldarius

  2011cites this paper
• Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.

  2010cites this paper
• Quantitative methods for studying DNA interactions with chemotherapeutic cisplatin

  2010cites this paper
• Non-traditional platinum compounds for improved cellular accumulation and tumor targeting

  2009cites this paper
• cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

  2008cites this paper
• Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.

  2008cites this paper
• The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

  2007cites this paper
• Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy

  2007cites this paper
• Biologic basis for combining drugs with radiation.

  2006cites this paper
• Flow Cytometric Analysis of DNA Damage and Repair in the Cells Resistant to Alkylating Agents1

  2006cites this paper
• Flow Cytometry Analysis of DNA Damage and the Evaluation of Cytotoxicity of Alkylating Agents 1

  2006cites this paper
• Target Practice: Figuring Out Which, When, and Why to Use Systemic Therapies for Metastatic Colon Cancer

  2006cites this paper
• CfVDiamminedichloroplatinum ( II )-induced DNA Adducts in Peripheral Leukocytes from Seven Cancer Patients : Quantitative Immunochemical Detection of the Adduct Induction and Removal after a Single Dose of cw-Diamminedichloroplatinum ( II ) 1

  2006cites this paper
• Flow Cytometric Analysis of DNA Damage and Repair in the Cells Resistant to Alkylating Agents 1

  2006cites this paper
• - Diamminedichloroplatinum ( II ) cis Induction and Removal after a Single Dose of Quantitative Immunochemical Detection of the Adduct Peripheral Leukocytes from Seven Cancer Patients :-Diamminedichloroplatinum ( II )-induced DNA Adducts in cis Updated

  2006cites this paper
• Immunocytoma Cisplatin-sensitive or-resistant Immunoglobulin M and Organs of Cisplatin-treated LOU / M Rats Inoculated with Platinum Concentrations and DNA Adduct Levels in Tumors

  2006cites this paper
• Resistance Patterns between m-Diamminedichloroplatinum(H) and Ionizing Radiation1

  2006cites this paper
• Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.

  2005cites this paper
• Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells

  2005cites this paper
• In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin.

  2005cites this paper
• Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides

  2004cites this paper
• Cisplatin nephrotoxicity.

  2003cites this paper
• Cisplatin-DNA adduct formation in rat spermatozoa and its effect on fetal development.

  2000cites this paper
• 32P-postlabeling assay for the quantification of the major platinum-DNA adducts.

  1999cites this paper
• Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.

  1997cites this paper
• Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.

  1997cites this paper
• Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.

  1997cites this paper
• Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin

  1996cites this paper
• The formation and persistence of carboplatin-DNA adducts in rats

  1996cites this paper
• In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.

  1996cites this paper
• Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.

  1996cites this paper
• Detection of platinum-DNA adducts by 32P-postlabelling.

  1995cites this paper
• The actual incision determines the efficiency of repair of cisplatin-damaged DNA by the Escherichia coli UvrABC endonuclease.

  1994cites this paper
• REVIEW: INTERACTIONS OF METAL IONS WITH NUCLEIC ACIDS AND THEIR SUBUNITS. AN ELECTROCHEMICAL APPROACH

  1994cites this paper
• The RAD7 and RAD16 genes, which are essential for pyrimidine dimer removal from the silent mating type loci, are also required for repair of the nontranscribed strand of an active gene in Saccharomyces cerevisiae

  1994cites this paper
• Molecular Aspects of Platinum-DNA Interactions

  1993cites this paper
• Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro.

  1992cites this paper
• Fast atom bombardment and high performance tandem mass spectrometry of platinum(II) oligodeoxyribonucleotide fragments

  1992cites this paper
• Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.

  1992cites this paper
• Immunochemical analyses of nucleic acids.

  1992cites this paper
• Platinum antitumour agents: A review of (bio)analysis

  1992cites this paper
• Histochemical and Immunohistochemical Techniques

  1991cites this paper
• Interactions of Platinum Amine Compounds with Sulfur-Containing Biomolecules and Dna Fragments

  1991cites this paper
• Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.

  1991cites this paper
• Biological Monitoring of Exposure to Polycyclic Aromatic Hydrocarbons

  1991cites this paper
• Monitoring human exposure to environmental carcinogens.

  1991cites this paper
• Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.

  1991cites this paper
• Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments.

  1991cites this paper
• Uvr excision repair protein complex of Escherichia coli binds to the convex side of a cisplatin-induced kink in the DNA.

  1991cites this paper
• Flow Cytometry to Characterize Normal and Abnormal Cell Function

  1991cites this paper
• DNA adducts in humans as biomarkers of exposure to environmental and occupational carcinogens

  1991cites this paper
• Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

  1991cites this paper
• A novel technique to assay adducts of DNA induced by anticancer agent cis-diamminedichloroplatinum(II).

  1991cites this paper
• Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro.

  1991cites this paper
• Cancer chemotherapy involving platinum and other platinum group complexes.

  1991cites this paper
• Platinum Nucleobase Chemistry

  1991cites this paper
• Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.

  1990cites this paper
• Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.

  1990cites this paper
• Decreased stability of DNA in cells treated with alkylating agents.

  1990cites this paper
• The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

  1990cites this paper
• Development of monoclonal antibodies recognizing 7-(2-hydroxyethyl)guanine and imidazole ring-opened 7-(2-hydroxyethyl)guanine.

  1990cites this paper
• Cisplatin and radiation: interaction probabilities and therapeutic possibilities.

  1990cites this paper
• Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.

  1990cites this paper
• Clastogenic effects of cis-diamminedichloroplatinum. II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice.

  1990cites this paper
• Detection of cells resistant to alkylating agents by flow cytometric analysis of DNA damage.

  1990cites this paper
• Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

  1990cites this paper
• Modern Methods of DNA Adduct Determination

  1990cites this paper
• Processing of UV-induced DNA damage in human skin cells

  1990cites this paper
• Molecular dosimetry of genotoxic damage.

  1989cites this paper
• Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels.

  1989cites this paper
• Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.

  1989cites this paper
• Interactions of Platinum Complexes with DNA Components

  1989cites this paper
• Application of new techniques for the detection of carcinogen adducts to human population monitoring.

  1988cites this paper
• Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.

  1988cites this paper
• DETECTION OF CYCLOBUTANE THYMINE DIMERS IN DNA OF HUMAN CELLS WITH MONOCLONAL ANTIBODIES RAISED AGAINST A THYMINE DIMER‐ CONTAINING TETRANUCLEOTIDE

  1988cites this paper
• Polyclonal Antibodies to DNA Modified with 4‐Nitroquinoline 1‐Oxide: Application for the Detection of 4‐Nitroquinoline 1‐Oxide‐DNA Adducts in vivo

  1988cites this paper
• Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.

  1988cites this paper
• Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.

  1988cites this paper
• In Vivo Cis-Diamminedichloroplatinum(II)-DNA Adduct Formation and Removal as Measured with Immunochemical Techniques

  1988cites this paper
• Platinum amine coordination compounds as anti-tumor drugs. Molecular aspects of the mechanism of action

  1987cites this paper
• cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).

  1987cites this paper
• Flow cytometry analysis of DNA damage and the evaluation of cytotoxicity of alkylating agents.

  1987cites this paper
• Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.

  1987cites this paper
• Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?

  1987cites this paper
• The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.

  1987cites this paper